AstraZeneca faking us out here? That chart looked ready to rip and now we're getting whipsawed! Meanwhile Bristol-Myers needs SERIOUS help — this thing's been dead money for way too long. Where's the pipeline catalyst? Where's the buyback aggression? BMY shareholders getting crushed while peers run. If you're in this one, you better have conviction on the oncology ramp because Mr. Market sure doesn't right now! Watch for support levels — if it breaks, it's UGLY! 💊📉